Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)
China · Delayed Price · Currency is CNY 5.36
-0.15 (-2.72%)
Jun 11, 2026, 3:00 PM CST
SHA:600381 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -61.27 | -36.08 | -198.77 | -267.87 | -287.55 | -248.61 |
Depreciation & Amortization | 24.92 | 24.92 | 29.4 | 27.54 | 41.51 | 42.01 |
Other Amortization | 4.17 | 4.17 | 4.16 | 2.26 | 1.11 | 1.23 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | 0.11 | -0 | -0.02 | 0.02 |
Asset Writedown & Restructuring Costs | 33.19 | 33.19 | 7.9 | 0.03 | 40.68 | - |
Loss (Gain) From Sale of Investments | -0.03 | -0.03 | 36.85 | 139.81 | 46.96 | 51.13 |
Provision & Write-off of Bad Debts | - | - | 10.83 | 9.72 | 26.7 | 58.58 |
Other Operating Activities | 78.87 | -5.84 | 5.68 | 4.42 | 52.45 | 38.12 |
Change in Accounts Receivable | 18.63 | 18.63 | 30.97 | 21.85 | 50.46 | -13.68 |
Change in Inventory | 6.39 | 6.39 | 118.01 | 34.74 | 8.82 | 2.21 |
Change in Accounts Payable | -78.51 | -78.51 | 43.63 | 52.54 | -4.38 | 9.83 |
Change in Other Net Operating Assets | -0.52 | -0.52 | -0.52 | -0.61 | -0.73 | -0.73 |
Operating Cash Flow | 33.11 | -26.41 | 80.97 | 23.92 | -31.82 | -63.93 |
Operating Cash Flow Growth | - | - | 238.56% | - | - | - |
Capital Expenditures | -6.67 | -6.55 | -4.93 | -13.53 | -0.82 | -121.79 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.16 | 0.01 | 0 | - |
Divestitures | -0.31 | - | - | - | - | - |
Investment in Securities | 19.5 | - | - | 1.5 | 35.5 | 150.45 |
Other Investing Activities | 0.12 | 0.05 | 0.19 | 0.15 | 1.48 | 20 |
Investing Cash Flow | 12.67 | -6.46 | -4.58 | -11.87 | 36.16 | 48.66 |
Long-Term Debt Repaid | - | - | -7.88 | -9.13 | -0.9 | -0.48 |
Total Debt Repaid | - | - | -7.88 | -9.13 | -0.9 | -0.48 |
Net Debt Issued (Repaid) | - | - | -7.88 | -9.13 | -0.9 | -0.48 |
Repurchase of Common Stock | - | - | -33.75 | - | - | - |
Other Financing Activities | -8.61 | -10.15 | - | 0.6 | - | - |
Financing Cash Flow | -8.61 | -10.15 | -41.62 | -8.53 | -0.9 | -0.48 |
Foreign Exchange Rate Adjustments | -0.41 | -0.31 | 0.19 | 0.06 | 0.31 | -0.17 |
Net Cash Flow | 36.75 | -43.34 | 34.96 | 3.57 | 3.75 | -15.93 |
Free Cash Flow | 26.44 | -32.96 | 76.04 | 10.39 | -32.64 | -185.73 |
Free Cash Flow Growth | - | - | 632.22% | - | - | - |
Free Cash Flow Margin | 8.71% | -9.60% | 28.14% | 4.86% | -20.38% | -145.37% |
Free Cash Flow Per Share | 0.05 | -0.06 | 0.13 | 0.02 | -0.06 | -0.31 |
Cash Income Tax Paid | 17.31 | 23.13 | 19.16 | 13.47 | -3.07 | 1.98 |
Levered Free Cash Flow | -37.94 | -124.96 | 139.89 | 62.45 | 57.37 | -83.72 |
Unlevered Free Cash Flow | -37.94 | -124.96 | 140.41 | 63.02 | 57.43 | -83.68 |
Change in Working Capital | -46.72 | -46.72 | 184.81 | 108.02 | 46.34 | -6.41 |